Montelukast

Alternative Names: Singulair

Singulair (montelukast) is a leukotriene receptor antagonist (LTRA) used to help control asthma and allergies. It blocks leukotrienes, inflammatory chemicals that cause airway constriction, mucus production, and inflammation and reduces asthma symptoms, particularly those triggered by allergies or exercise.

Treatment Type: Prescription Medication

Treatment Class: Leukotriene antagonist

Treatment Modality: Oral

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the single review provided by Dr. Curbside, Montelukast (Singulair) appears to be an effective second-line or add-on therapy for asthma, particularly for cases triggered by allergies or exercise. However, inhaled corticosteroids are still considered the primary first-line controller treatment for asthma management.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
3.0
1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the single review provided by Dr. Curbside, Montelukast (Singulair) appears to be an effective second-line or add-on therapy for asthma, particularly for cases triggered by allergies or exercise. However, inhaled corticosteroids are still considered the primary first-line controller treatment for asthma management.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
5 months ago
Singulair is a solid second-line or add-on option for asthma, especially if symptoms are triggered by allergies or if exercise-induced bronchospasm is a big issue. It can help smooth out those flare-ups, but inhaled corticosteroids are still the first-line controller therapy for most patients. One thing to watch for is the potential for side effects like vivid or unusual dreams, which some people experience. Overall, it’s a helpful add-on when asthma isn’t fully controlled with standard treatments.
#VeryAffordable #CoveredByInsurance #ModerateRelief #ModerateEffect #Second-line #Maintenance #Supportive/Add-OnTreatment